Raffa Wealth Management’s Texas Capital Bancshares, Inc. Common Stock, par value $0.01 per share TXCP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$103 Hold
1
– – ﹤0.01% 1384
2026
Q1
$95 Buy
+1
New +$98 ﹤0.01% 1299
2017
Q1
– Sell
-8
Closed -$627 – 803
2016
Q4
$627 Hold
8
– – ﹤0.01% 643
2016
Q3
$439 Hold
8
– – ﹤0.01% 773
2016
Q2
$374 Hold
8
– – ﹤0.01% 787
2016
Q1
$307 Hold
8
– – ﹤0.01% 800
2015
Q4
$395 Hold
8
– – ﹤0.01% 763
2015
Q3
$419 Hold
8
– – ﹤0.01% 733
2015
Q2
$498 Buy
+8
New +$438 ﹤0.01% 725

Other funds holding TXCP

Raffa Wealth Management's TXCP Position: Q2 2026 in Review

Raffa Wealth Management held its Texas Capital Bancshares, Inc. Common Stock, par value $0.01 per share (TXCP) position steady in Q2 2026 at 1 share worth $103. The position accounts for ﹤0.01% of the portfolio, ranked #1384.

Raffa Wealth Management first reported a position in TXCP in Q2 2015 and has held it in 9 quarters since. The position peaked at $627 in Q4 2016. 377 funds tracked by Wall St. Rank hold TXCP as of Q2 2026.

  • Raffa Wealth Management held 1 share of Texas Capital Bancshares, Inc. Common Stock, par value $0.01 per share worth $103 as of Q2 2026.
  • Raffa Wealth Management left its Texas Capital Bancshares, Inc. Common Stock, par value $0.01 per share share count unchanged in Q2 2026.
  • Texas Capital Bancshares, Inc. Common Stock, par value $0.01 per share made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #1384 holding.
  • Raffa Wealth Management first reported a position in Texas Capital Bancshares, Inc. Common Stock, par value $0.01 per share in Q2 2015 and has held it in 9 quarters since.
  • Raffa Wealth Management's Texas Capital Bancshares, Inc. Common Stock, par value $0.01 per share position peaked at $627 in Q4 2016.
  • 377 funds tracked by Wall St. Rank held Texas Capital Bancshares, Inc. Common Stock, par value $0.01 per share as of Q2 2026.

Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.